LpMab-23-recognizing cancer-type podoplanin is a novel predictor for a poor prognosis of early stage tongue cancer.
about
LpMab-23-recognizing cancer-type podoplanin is a novel predictor for a poor prognosis of early stage tongue cancer.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
LpMab-23-recognizing cancer-ty ...... of early stage tongue cancer.
@en
LpMab-23-recognizing cancer-ty ...... of early stage tongue cancer.
@nl
type
label
LpMab-23-recognizing cancer-ty ...... of early stage tongue cancer.
@en
LpMab-23-recognizing cancer-ty ...... of early stage tongue cancer.
@nl
prefLabel
LpMab-23-recognizing cancer-ty ...... of early stage tongue cancer.
@en
LpMab-23-recognizing cancer-ty ...... of early stage tongue cancer.
@nl
P2093
P2860
P356
P1433
P1476
LpMab-23-recognizing cancer-ty ...... of early stage tongue cancer.
@en
P2093
Akihiro Miyazaki
Hiromi Nakai
Hiroyoshi Hiratsuka
Mika K Kaneko
Tomoko Sonoda
Yoshihiko Hirohashi
Yoshihiko Sawa
P2860
P304
21156-21165
P356
10.18632/ONCOTARGET.24986
P407
P577
2018-04-20T00:00:00Z